PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 67 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $316,066 | -67.7% | 351,834 | -62.6% | 0.00% | -71.4% |
| Q4 2022 | $979,461 | -19.8% | 941,834 | -11.3% | 0.01% | -22.2% |
| Q3 2022 | $1,221,000 | -38.5% | 1,061,834 | 0.0% | 0.01% | -43.8% |
| Q2 2022 | $1,986,000 | -38.3% | 1,061,834 | 0.0% | 0.02% | -27.3% |
| Q1 2022 | $3,217,000 | -19.9% | 1,061,834 | 0.0% | 0.02% | -15.4% |
| Q4 2021 | $4,014,000 | -26.9% | 1,061,834 | 0.0% | 0.03% | -29.7% |
| Q3 2021 | $5,489,000 | +35.0% | 1,061,834 | 0.0% | 0.04% | +32.1% |
| Q2 2021 | $4,067,000 | -25.5% | 1,061,834 | -53.3% | 0.03% | -37.8% |
| Q1 2021 | $5,458,000 | -3.9% | 2,272,727 | -0.0% | 0.04% | 0.0% |
| Q4 2020 | $5,682,000 | +18.9% | 2,272,731 | -1.5% | 0.04% | 0.0% |
| Q3 2020 | $4,777,000 | -34.3% | 2,307,814 | -1.6% | 0.04% | -41.6% |
| Q2 2020 | $7,271,000 | +38.1% | 2,345,468 | +57.6% | 0.08% | +32.8% |
| Q1 2020 | $5,266,000 | -2.2% | 1,488,175 | +0.0% | 0.06% | 0.0% |
| Q4 2019 | $5,387,000 | +139.3% | 1,488,069 | +125.5% | 0.06% | +93.3% |
| Q3 2019 | $2,251,000 | – | 660,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |